以腰痛为首发症状的肥大细胞白血病1例

doi:10.3760/cma.j.issn.1007-1245.2023.04.029

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (4): 569-571.DOI: 10.3760/cma.j.issn.1007-1245.2023.04.029

以腰痛为首发症状的肥大细胞白血病1例

李芳¹ 蔄雯瑜² 于雅宁¹ 葛凤华¹ 孙祥君³

¹威海市中心医院检验科，威海　264400；²威海市中心医院病理科，威海　264400；³威海市中心医院血液科，威海　264400

收稿日期:2022-06-28 出版日期:2023-03-15 发布日期:2023-03-06
通讯作者: 李芳，Email：514350065@qq.com

A case of mast cell leukemia with lumbago as the first symptom

Li Fang¹, Man Wenyu², Yu Yaning¹, Ge Fenghua¹, Sun Xiangjun³

¹Clinical Laboratory, Weihai Central Hospital, Weihai 264400, China; ²Department of Pathology, Weihai Central Hospital, Weihai 264400, China; ³Department of Hematology, Weihai Central Hospital, Weihai 264400, China

Received:2022-06-28 Online:2023-03-15 Published:2023-03-06
Contact: Li Fang, Email: 514350065@qq.com

摘要/Abstract

摘要：

为提高罕见白血病的诊断水平，本文报道1例以腰痛为首发症状的肥大细胞白血病（mast cell leukemia，MCL）患者的临床资料，并进行文献复习，以提高检验工作者对MCL的诊断水平。

关键词:

肥大细胞, 白血病, 腰痛

Abstract:

To improve the diagnostic level of rare leukemia, the clinical data of a patient with mast cell leukemia (MCL) and lumbago as the first symptom were reported and the literatures were reviewed to improve the diagnostic level of MCL.

Key words:

Mast cell, Leukemia, Lumbago

李芳蔄雯瑜于雅宁葛凤华孙祥君.

以腰痛为首发症状的肥大细胞白血病1例 [J]. 国际医药卫生导报, 2023, 29(4): 569-571.

Li Fang, Man Wenyu, Yu Yaning, Ge Fenghua, Sun Xiangjun.

A case of mast cell leukemia with lumbago as the first symptom [J]. International Medicine and Health Guidance News, 2023, 29(4): 569-571.

参考文献

[1] 卢兴国, 叶向军, 徐根波, 等.骨髓细胞与组织病理诊断学.北京:人民卫生出版社, 2020: 590.
[2] Jain P, Wang S, Patel KP, et al. Mast cell leukemia (MCL): clinico-pathologic and molecular features and survival outcome [J]. Leuk Res, 2017, 59:105-109. DOI: 10.1016/j.leukres.2017.05.018.
[3] Valent P, Sotlar K, Sperr WR, et al. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal [J]. Ann Oncol, 2014, 25(9):1691-1700. DOI: 10.1093/annonc/mdu047.
[4] Galura GM, Cherukuri SV, Hakim N, et al. Acute aleukemic mast cell leukemia:report of a case and review of the literature [J]. Leuk Res Rep, 2020, 14: 100230. DOI: 10.1016/j.lrr.2020.100230.
[5] Chiu A, Orazi A. Mastocytosis and related disorders [J]. Semin Diagn Pathol, 2012, 29(1): 19-30. DOI: 10.1053/j.semdp.2011.06.002.
[6] Costopoulos M, Uzunov M, Bories D, et al Acute mast cell leukemia: a rare but highly aggressive hematopoietic neoplasm [J]. Diagn Cytopathol, 2018, 46(7): 639-641. DOI: 10.1002/dc.23965.
[7] Sotlar K, Cerny-Reiterer S, Petat-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis [J]. Mod Pathol, 2011, 24(4): 585-595. DOI: 10.1038/modpathol.2010.224.
[8] Reiter A, George TI, Gotlib J. New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis [J]. Blood, 2020, 135(16):1365-1376. DOI: 10.1182/blood.2019000932.
[9] Jawhar M, Schwaab J, Schnittger S, et al. Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event [J]. Leukemia, 2015, 29(5):1115-1122. DOI: 10.1038/leu.2015.4.
[10] Gilreath JA, Tchertanov L, Deininger MW. Novel approaches to treating advanced systemic mastocytosis [J]. Clin Pharmacol, 2019, 11:77-92. DOI: 10.2147/CPAA.S206615.
[11] Leguit R, Hebeda K, Kremer M, et al. The Spectrum of aggressive mastocytosis: a workshop report and literature review [J]. Pathobiology, 2020, 87(1):2-19. DOI: 10.1159/000504099.
[12] Apsel Winger B, Cortopassi WA, Garrido Ruiz D, et al. ATP-competitive inhibitors midostaurin and avapritinib have distinct resistance profiles in exon 17-mutant KIT [J]. Cancer Res, 2019, 79(16): 4283-4292. DOI: 10.1158/0008-5472.CAN-18-3139.

以腰痛为首发症状的肥大细胞白血病1例

A case of mast cell leukemia with lumbago as the first symptom

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics